These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 35090939

  • 1. Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach.
    Ganeshpurkar A, Singh R, Kumar D, Gore P, Shivhare S, Sardana D, Rayala S, Kumar A, Singh SK.
    Int J Biol Macromol; 2022 Apr 01; 203():195-211. PubMed ID: 35090939
    [Abstract] [Full Text] [Related]

  • 2. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S, Jończyk J, Bajda M, Khan IU, Khan MA, Ullah N, Ashraf M, Qurat-ul-Ain, Riaz S, Hussain S, Yar M.
    Bioorg Chem; 2016 Feb 01; 64():13-20. PubMed ID: 26595185
    [Abstract] [Full Text] [Related]

  • 3. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
    Abdullaha M, Nuthakki VK, Bharate SB.
    Eur J Med Chem; 2020 Dec 01; 207():112761. PubMed ID: 32942070
    [Abstract] [Full Text] [Related]

  • 4. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 01; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 5. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
    Bilen E, Özdemir Özmen Ü, Çete S, Alyar S, Yaşar A.
    Chem Biol Interact; 2022 Jun 01; 360():109956. PubMed ID: 35452634
    [Abstract] [Full Text] [Related]

  • 6. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S, Prajapati SK, Majumdar S, Raza MK, Gabr MT, Kumar S, Pal K, Rashid H, Kumar S, Krishnamurthy S, Hoda N.
    Eur J Med Chem; 2021 Apr 05; 215():113224. PubMed ID: 33582578
    [Abstract] [Full Text] [Related]

  • 7. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile.
    Makhaeva GF, Kovaleva NV, Boltneva NP, Rudakova EV, Lushchekina SV, Astakhova TY, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Korabecny J, Soukup O, Bachurin SO, Richardson RJ.
    Molecules; 2022 Feb 04; 27(3):. PubMed ID: 35164325
    [Abstract] [Full Text] [Related]

  • 8. Identification of Compounds for Butyrylcholinesterase Inhibition.
    Li S, Li AJ, Travers J, Xu T, Sakamuru S, Klumpp-Thomas C, Huang R, Xia M.
    SLAS Discov; 2021 Dec 04; 26(10):1355-1364. PubMed ID: 34269114
    [Abstract] [Full Text] [Related]

  • 9. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
    Taha M, Rahim F, Uddin N, Khan IU, Iqbal N, Anouar EH, Salahuddin M, Farooq RK, Gollapalli M, Khan KM, Zafar A.
    Int J Biol Macromol; 2021 Oct 01; 188():1025-1036. PubMed ID: 34390751
    [Abstract] [Full Text] [Related]

  • 10. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M, Chehardoli G, Bahiraei M, Akbarzadeh T, Ranjbar A, Rastegari A, Najafi Z.
    Mol Divers; 2022 Feb 01; 26(1):489-503. PubMed ID: 34491490
    [Abstract] [Full Text] [Related]

  • 11. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB, Talhi O, Silva ASM, Senol FS, Orhan IE, Rauf A, Mabkhot YN, Bachari K, Warad I, Farghaly TA, Althagafi II, Mubarak MS.
    Mini Rev Med Chem; 2018 Feb 01; 18(8):711-716. PubMed ID: 28714400
    [Abstract] [Full Text] [Related]

  • 12. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M.
    Arch Pharm (Weinheim); 2017 Apr 01; 350(3-4):. PubMed ID: 28220522
    [Abstract] [Full Text] [Related]

  • 13. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
    Purgatorio R, de Candia M, Catto M, Carrieri A, Pisani L, De Palma A, Toma M, Ivanova OA, Voskressensky LG, Altomare CD.
    Eur J Med Chem; 2019 Sep 01; 177():414-424. PubMed ID: 31158754
    [Abstract] [Full Text] [Related]

  • 14. Anti-Cholinesterase Activity of Chalcone Derivatives: Synthesis, In Vitro Assay and Molecular Docking Study.
    Riswanto FDO, Rawa MSA, Murugaiyah V, Salin NH, Istyastono EP, Hariono M, Wahab HA.
    Med Chem; 2021 Sep 01; 17(5):442-452. PubMed ID: 31808389
    [Abstract] [Full Text] [Related]

  • 15. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
    Iqbal J, Abbasi MSA, Zaib S, Afridi S, Furtmann N, Bajorath J, Langer P.
    Med Chem; 2018 Sep 01; 14(8):809-817. PubMed ID: 29473519
    [Abstract] [Full Text] [Related]

  • 16. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H, Jiang Y, Zhan J, Sun Y.
    Bioorg Chem; 2021 Sep 01; 114():105149. PubMed ID: 34252860
    [Abstract] [Full Text] [Related]

  • 17. Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer's Disease.
    Lu X, Li Y, Guan Q, Yang H, Liu Y, Du C, Wang L, Wang Q, Pei Y, Wu L, Sun H, Chen Y.
    ACS Chem Neurosci; 2024 Mar 20; 15(6):1135-1156. PubMed ID: 38453668
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Bachurin SO, Richardson RJ.
    Bioorg Med Chem; 2016 Mar 01; 24(5):1050-62. PubMed ID: 26827140
    [Abstract] [Full Text] [Related]

  • 19. Discovery of quinazolin-4(3H)-one derivatives as novel AChE inhibitors with anti-inflammatory activities.
    Lv L, Maimaitiming M, Huang Y, Yang J, Chen S, Sun Y, Zhang X, Li X, Xue C, Wang P, Wang CY, Liu Z.
    Eur J Med Chem; 2023 Jun 05; 254():115346. PubMed ID: 37043994
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
    Matošević A, Opsenica DM, Spasić M, Maraković N, Zandona A, Žunec S, Bartolić M, Kovarik Z, Bosak A.
    Chem Biol Interact; 2023 Sep 01; 382():110620. PubMed ID: 37406982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.